With a 392-28 vote, the House of Representatives passed a bill June 8 intended to alter the FDA’s accelerated-approval process after some “costly, ineffective drugs” hit pharmacy shelves, The Wall Street Journal reported.
Read the full post on Becker's Hospital Review - Healthcare News
